Background. The association of antibody responses with both innate and acquired immunity to amebiasis indicate that CD4 + T cells play a role in protection against Entamoeba histolytica infection. To test this hypothesis, we compared the genotype frequencies of human leukocyte antigen (HLA) class II alleles in a cohort of Bangladeshi children intensively monitored for E. histolytica infection for a 3-year period.
cluding amebic liver abscess [1, 2] . Most infections occur in the developing world in areas with poor sanitation and living conditions. For example, preschool children in an urban slum of Dhaka, Bangladesh, had an annual incidence of amebic dysentery of 2% [3] . Adults in Hue, Vietnam, were estimated to have an annual incidence of amebic liver abscess of 21 cases/ 100,000 population [4] . Overall, the World Health Organization estimates that E. histolytica infection results in 100,000 deaths/year, second only to malaria as a protozoan cause of mortality [5] .
For the past 3 years, we have studied the natural history of amebiasis in a cohort of children who live in an urban slum in Dhaka. In these children, only 1 in 5 E. histolytica infections results in disease [3] . The host and parasite factors that influence susceptibility to infection and disease are not well understood. E. histolytica appears to lack a sexual cycle, suggesting that genetic differences between parasite isolates are unlikely to completely explain the different outcomes of infec-tion [6, 7] . In the present study, we examine host genes that could influence susceptibility to amebiasis in our cohort of Bangladeshi children.
In previous studies of this cohort, innate immunity to infection was associated with a lack of serum anti-amebic IgG antibodies. Children who lacked serum anti-amebic antibodies at entry into the study had 50% fewer E. histolytica infections at 1 year of observation [8] . These children also had a significantly shorter duration of infection and lower ratio of symptomatic to asymptomatic infections [3] . Most children who lacked serum anti-amebic IgG antibodies failed to develop such antibodies if they became infected, which suggests that there may be a genetic predisposition to the absence of a serum IgG response, not simply a lack of exposure to the parasite. Consistent with genetic inheritance, the serum anti-amebic IgG response clustered in families. We have postulated that the presence of serum anti-amebic IgG antibodies is a marker for inadequate intestinal innate immune responses that can lead to parasite invasion. Conversely, children who lack serum antiamebic IgG are hypothesized to have a more robust innate immune response, which prevents parasite invasion into the intestinal epithelium, thereby preventing a systemic IgG antiparasite immune response.
In contrast, acquired immunity is associated with a mucosal IgA antibody response against the parasite galactose (Gal)/Nacetylgalactosamine (GalNAc) lectin and, specifically, its carbohydrate-recognition domain (CRD). Children with IgA antibodies against the Gal/GalNAc lectin CRD in their stool had 86% fewer new infections at 1 year of observation [3] . The Gal/ GalNAc lectin is present on the trophozoite plasma membrane, where it is required for parasite adherence to and contactdependent killing of host cells. Consistent with its role as a virulence factor, immunization with the Gal/GalNAc lectin has been shown to prevent amebiasis in animal models [9] .
Because anti-amebic IgG and IgA responses are associated with susceptibility and resistance to infection, respectively, it is biologically plausible that major histocompatibility complex (MHC) class II alleles affect both the acquisition of amebiasis and disease burden. To test this hypothesis, we determined the MHC class II genotype frequencies in our cohort of Bangladeshi children who had been monitored every other day for the last 3 years for E. histolytica infection. In addition, we tested for an association between MHC class II genotype frequencies and serum anti-amebic IgG response and stool anti-CRD IgA response.
SUBJECTS, MATERIALS, AND METHODS
Study subjects. In 1999, 289 preschool children (2-5 years old) from Mirpur, an urban slum in Dhaka were enrolled in a prospective study, as described elsewhere [3, 8] . The inhabitants of Mirpur are of Bihari ethnic origin and settled there after the liberation of Bangladesh from Pakistan in 1971. The area is separated into East and West sections by a road; both sections are densely populated and have poor sanitary and hygienic conditions. The children and their parents were visited and interviewed every other day by health-care workers for information about any diarrheal episodes of the child, as well as other related questions. Diarrheal episodes were also detected when parents contacted project personnel at the field clinic. When diarrheal disease was detected, the child was examined, and a stool sample was obtained for detailed investigation of enteropathogens, including E. histolytica. Surveillance stool specimens were obtained every month for detection of E. histolytica infection by use of the E. histolytica II test (TechLab), which was designed to detect specifically E. histolytica and not the closely related nonpathogen E. dispar, performed according to the manufacturer's instructions. Stool samples were also cultured for Entamoeba species in Robinson's medium within 6 h of collection. Blood samples were obtained from these children every 4 months and were tested for serum anti-parasite antibodies. After 3 years, 220 children remained in the study. The present investigation includes 185 children from this cohort who represented nuclear families.
Informed consent was obtained from the parents or guardians, and the human experimentation guidelines of the US Department of Health and Human Services, the University of Virginia, the Johns Hopkins University Bloomberg School of Public Health, and the Centre for Health and Population Research, International Centre for Diarrheal Disease Research, Bangladesh, were followed in the conduct of this research.
An incident E. histolytica infection during the period of observation was defined as a stool sample with a positive E. histolytica antigen test or culture result preceded by 12 monthly surveillance stool samples with negative results. Initial analysis defined case and control subjects as children without and children with E. histolytica infection, respectively. Because antiparasite IgG response is associated with the acquisition of E. histolytica infection, we used a more-specific case-control definition for subsequent analyses. Case subjects were defined according to 1 of the 5 following categories: (1) "not infected," children negative for both E. histolytica infection and serum antiparasite IgG during the period of observation; (2) "not infected, exposed," children negative for E. histolytica infection but who became positive for serum anti-parasite IgG; (3) "amebic colonized," children positive for a single E. histolytica infection and negative for serum anti-parasite IgG during the entire period of observation; (4) "amebic colonized, multiple infections," children positive for multiple E. histolytica infections and negative for serum anti-parasite IgG during the observation period; and (5) "invasive," children positive for a single E. histolytica infection and positive for serum anti-parasite IgG. Table 2 .
Frequency of DRB1 alleles in a cohort of Bangladeshi children. The control group included 6 children who had received diagnoses of multiple E. histolytica infections and who were positive for serum anti-parasite IgG (invasive, multiple infections). According to this definition, the 5 case groups were mutually exclusive. Laboratory analysis and HLA class II typing. Serum antiparasite IgG and stool IgA antibodies against the parasite and the Gal/GalNAc lectin were determined by use of ELISA using 96-well plates, as described elsewhere [3, 8] . DNA was purified from 200 mL of peripheral blood obtained from the children. Genomic DNA was isolated with Qiagen spin columns after the use of Qiagen protease and lysing buffer, according to the manufacturer's instructions. The DNA was eluted from the membrane with an elution buffer, according to Qiagen's protocol. HLA class II typing was performed by use of the polymerase chain reaction (PCR) and sequence-specific oligonucleotide method at Dynal (Bromborough, UK) [10, 11] . Statistical analysis. Allele frequencies for HLA class II DRB1 and DQB1 alleles were estimated from the entire cohort by counting methods. Common alleles with frequencies of 110% in this population were used in case-control comparisons. The assignment of likely haplotypes was made by use of the program Phase 1.0 [12] , which uses a Bayesian method based on a coalescent model. The genotypes of HLA class II alleles were compared between children for each clinical category. The magnitude of the association between HLA markers and the occurrence of E. histolytica infection was measured with the odds ratio (OR) by use of polymotous logistic regression, which reflects the likelihood of having a particular clinical outcome given the observed genotype. The conservative Bonferroni correction was used to account for multiple comparisons ( ; 5 alleles and 1 haplotype). Pairwise linkage disequilibn p 6 rium was calculated by use of the statistical software Arlequin 2.0 [13] . All regression and Kaplan-Meier analyses were computed by use of Stata software (version 6.0; StataCorp).
RESULTS
To determine the effect of HLA class II genotype on susceptibility to E. histolytica infection, we examined 185 children (370 alleles) from the Mirpur urban slum of Dhaka. The children enrolled were 2-5 years old and were monitored every other day for an average of 2.8 years for E. histolytica infection. Among those with E. histolytica infection during the study period ( ), 90 (70%) were serum anti-parasite IgG positive n p 129 at some time, compared with 37 (66%) of 56 children without infection. The cohort was evenly distributed by sex, mean age, and region within Mirpur (table 1) .
As expected, both the DQB1 and DRB1 loci had a large number of allelic variants, with frequencies ranging from !1% to 33%. HLA class II DQB1 and DRB1 alleles showed no deviation from Hardy-Weinberg equilibrium (tables 2 and 3). To maximize statistical power, we limited our tests for association analysis to alleles with frequencies у10%. The DQB1*0601 ; Bonferroni-corrected P [P c ).
] p .04 This apparent protective association was not seen in the subset of children who were homozygous for the DQB1*0601 allele. Children who were heterozygous for the DQB1*0601 allele were clearly overrepresented among control subjects, even after adjusting for the DQB1*0202 and DQB1*0301 alleles, age, sex, and region within Mirpur (OR, 2.69; 95% CI, 1.31-5.52; ; ). Kaplan-Meier survival curves of time to P p .007 P p .035 c E. histolytica infection demonstrated that the protective effect associated with the DQB1*0601 allele was a delay in onset of infection and not complete protection against infection (figure 1). The decreased risk of E. histolytica infection among children who were heterozygous for DQB1*0601 was consistent with an allelic association that was seen when allele frequencies, rather than genotype frequencies, were compared by infection status, although this did not reach statistical significance after correction (OR, 1.60; 95% CI, 0.98-2.63; ; ). P p .06 P p .30 c Similarly, the DRB1*1501 heterozygous and homozygous genotypes combined were present in 53% of E. histolyticanegative children but in only 34% of E. histolytica-positive children (OR, 2.17; 95% CI, 1.13-4.17; ; ). This P p .02 P p .10 c apparent protective pattern was most prominent for children who were heterozygous for DRB1*1501 (OR, 2.72; 95% CI, 1.36-5.43; ; ) and was not seen in children who P p .004 P p .025 c were homozygous for this allele (data not shown). Genotype frequencies of the other class II alleles (DRB1*0701, DQB1*0202, and DQB1*0301) were evenly distributed among E. histolyticapositive and -negative children and showed no evidence of association with E. histolytica infection (data not shown).
To determine whether the apparent protective association of the genotypes DQB1*0601 and DRB1*1501 with E. histolytica infection was influenced by serum anti-parasite IgG response and number of E. histolytica infections, we further narrowed our categories of response to E. histolytica infection (table 4) . We defined 5 clinical case outcomes: not infected; not infected but exposed; amebic colonization with single infection; amebic colonization with multiple infections; and invasive single infection. The control group was defined as children with invasive disease and multiple infections. Children carrying the DQB1*0601 allele were more likely to be uninfected (both E. histolytica negative and serum anti-parasite IgG negative) (adjusted OR, 7.81; 95% CI, 1.92-31.7; ; ) (table P p .004 P p .02 c 4). This association persisted for the other categories, although the strength of the association was consistently higher for children who were not infected with E. histolytica during the observation period. Genotypes carrying DQB1*0202, DQB1*0301, and DRB1*0701 alleles showed no evidence of statistical association with the presence of E. histolytica infection or serum anti-parasite IgG (data not shown).
Because the abundance of HLA class II alleles results in some interdependence among allelic classes, we estimated the DQB1/ DRB1 haplotypes for this Bangladeshi population and then calculated the amount of linkage disequilibrium between alleles. DQB1*0601 and DRB1*1501 formed the most common hap- (table 6 ). There was no association for children who were homozygous for the DQB1*0601/DRB1*1501 haplotype or for children who carried only the DRB1*1501 allele. This result suggests that the DRB1*1501 allele alone has no association with E. histolytica infection. Nearly every child who was homozygous for DQB1*0601 was also homozygous for the haplotype DQB1*0601/DRB1*1501 (16/17 children).
To determine whether the class II DQB1*0601 allele and DQB1*0601/DRB1*1501 haplotype was also associated with acquired immunity, we compared alleles and haplotypes to stool anti-CRD IgA responses. We did not find any statistical association in multivariate logistic regression for DQB1*0601 heterozygotes (OR, 1.41; 95% CI, 0.64-3.11), DQB1*0601 homozygotes (OR, 0.43; 95% CI, 0.14-1.23), or DQB1*0601/DRB1*1501 heterozygotes (OR, 1.77; 95% CI, 0.75-4.17), adjusted for age, sex, and region in Mirpur.
DISCUSSION
One of the great unanswered questions in amebiasis is why only a minority of persons infected with E. histolytica develop disease. The cohort of Bangladeshi children provided a unique opportunity to investigate human genes that could influence susceptibility to infection. The children in this cohort have been closely observed for E. histolytica infection for the last 3 years using highly sensitive and specific antigen detection, PCR, and culture and serologic methods. Most of the children have experienced at least 1 amebic infection during the period of observation, with varied degrees of disease resulting from infection. We hypothesized that HLA class II alleles could influence susceptibility, because we had previously found an association of systemic and mucosal antibody responses with infection and disease in these children [3, 8] .
The most important finding of the present study was the demonstration that host genes underlie susceptibility to human intestinal amebiasis. A protective association of the HLA class II allele DQB1*0601 and the heterozygous haplotype DQB1*0601/DRB1*1501 with E. histolytica infection and disease was present in this cohort. The other DQB1 and DRB1 alleles (DQB1*0202, DQB1*0301, and DRB1*0701) and genotypes showed no evidence of association in this population with any of the clinical outcomes related to amebiasis. At this time, it is not possible to know whether the DQB1*0601 allele is directly responsible for the protection observed or whether it is in linkage disequilibrium with an unknown gene controlling resistance to E. histolytica.
The HLA complex on chromosome 6 contains 1200 genes that are divided into 3 classes. Class I and II gene products function to present foreign antigens, processed into short peptides, to the immune system. The extensive polymorphism of HLA class I and II genes may be maintained by genetic pressure that results from the need to present many different foreign peptides to the immune system to effectively combat multiple different and potentially lethal infectious diseases. The HLA class II genes function to present to CD4 + T cells peptides generated by the endocytic protein-processing pathway from endocytosed proteins of infectious pathogens, such as E. histolytica. Most HLA class II processing occurs in the "professional" antigen-presenting B cells, macrophages, and dendritic cells. A single HLA class II allele is thought to be capable of presenting several thousand different peptides to a CD4 + T cell. The peptide-binding groove of the HLA class II molecule is open-ended and accommodates peptides that are longer (115 residues) and with less-restricted amino-terminal sequences than peptides presented by class I alleles.
It is possible that the presence or absence of a particular HLA class II allele could alter the response to an infection by changing the repertoire of proteins presented to CD4 + T cells. In support of this hypothesis, several previous studies have demonstrated associations of HLA class II alleles with the susceptibility or course of infectious disease. These have included the association of the class II HLA-DRB1*1302/DQB1*0501 haplotype with mild Plasmodium falciparum malaria in The Gambia [14] , class II DR*04 alleles with more-severe malaria in Gabon [15] , and a controversial proposed role for a specific variable region, as opposed to an allele (position 11 of the class II DP alpha chain), in the outcome of Onchocerca volvulus and Schistosoma haematobium infections [15, 16] . The HLA-DRB1*1302 allele is associated with the clearance of hepatitis B virus in The Gambia [17] , and, conversely, class II DQA1*0501 and DQB1*0301 alleles are associated with persistent hepatitis B virus infection in African Americans [18] . Of interest, resistance to infection with human papilloma virus type 16 is associated with DQB1*0602 and DRB1*1501, a haplotype similar to the one identified here [19] .
Previous studies have shown an association between HLA class II alleles and susceptibility to amebic liver abscess but not to intestinal amebiasis [20, 21] . Because amebic liver abscess is primarily a disease of adult men, we observed no cases in our cohort and thus could not draw conclusions about its association with HLA class II alleles. The earlier study of intestinal amebiasis used a serologic typing method for HLA class II that was unable to resolve the DRB1 and DQB1 alleles and therefore could not detect the association between DQB1*0601 and protection that we observed here [20, 21] . An increased frequency of HLA-DR3 was identified in Mexican mestizo adults and children with amebic liver abscess, compared with healthy control subjects [21] . We did not detect a similar association between DR3 alleles and susceptibility to intestinal amebiasis (data not shown), which suggests that there may be different genes influencing susceptibility to intestinal and hepatic amebiasis.
Our finding of the association of the HLA class II allele DQB1*0601 and the heterozygous haplotype DQB1*0601/ DRB1*1501 with E. histolytica infection and disease supports a role for HLA class II antigen processing and CD4 + T cells in resistance to amebiasis. A protective role for CD4 + T cells had previously been suggested by the association between IgA mucosal antibody responses and susceptibility, as well as the ability of CD4 + T cells to activate macrophages in vitro to kill the trophozoite [3, 8] . In a mouse model of amebic colitis, CD4 + T cells have also been shown to have the potential to exacerbate disease [22] .
The lack of association with disease for children who are homozygous for the DQB1*0601/DRB1*1501 haplotype, as opposed to those who are heterozygous for that haplotype, is not without precedent. MHC heterozygotes have a selective advantage in that they can present a wider variety of antigens to T lymphocytes than homozygotes. Heterozygosity of HLA alleles has also been associated with resistance to infectious diseases (specifically, HIV and hepatitis C virus), presumably a result of this greater variety of peptides that can be presented to the immune system [18, 23] .
In summary, our work provides evidence to support earlier observations from this Bangladeshi cohort that children differ in their genetic susceptibility to intestinal amebiasis. Future work will include examination of HLA class I alleles to test for linkage disequilibrium across the class I and class II genes, to better determine the extent of genetic resistance to amebiasis. The ultimate understanding of the human genes that underlie susceptibility should provide insight into the role of the acquired and innate immune systems in protection against amebiasis.
